Jian-Kang Chen is an Associate Professor at Augusta University's Medical College of Georgia in the Department of Cellular Biology & Anatomy with a secondary appointment in the Department of Medicine. His research focuses on molecular mechanisms of kidney growth and injury, particularly the role of autophagy, mTOR signaling, and growth factor pathways in compensatory renal hypertrophy and proteinuric kidney diseases. Autophagy and Cell Survival Nephron Growth Signaling Podocyte Biology in Diabetic Nephropathy Mouse Models of Renal Injury Molecular Pathways in Renal Fibrosis His work identifies amino acid delivery via increased renal blood flow as a key trigger for mTORC1-S6K1 pathway activation, which regulates kidney size post-nephrectomy or diabetes. He has pioneered mouse models targeting Tsc1 , Pten , and Pik3c3 to dissect context-dependent signaling mechanisms. His 15 most recent publications highlight trends in exosome biology, autophagy regulation, and EGFR signaling in kidney injury. Notable contributions include identifying mTORC1 as a central mediator of renal hypertrophy and establishing the role of VPS34 in podocyte vesicle trafficking. 2009 American Journal of Physiology-Renal Physiology Paper of the Year Chen's lab trains graduate student Desmond Moronge and has received funding from the American Heart Association, NIH/NIDDK, and Augusta University start-up grants. His team investigates therapeutic targets to prevent end-stage renal disease through preclinical models like unilateral nephrectomy and diabetic nephropathy.
Anne Druilhe is a researcher at Inserm U1248 Laboratory (P&T Laboratory) affiliated with the University of Limoges' Faculty of Medicine and Pharmacy. Her work focuses on pharmacomicrobiomics , investigating bidirectional interactions between immunosuppressive drugs and gut microbiota in transplant patients, alongside digestive immunology mechanisms involving immunoglobulin A. Teaching : Coordinates animal research ethics training programs across multiple French institutions Leadership : Served as Director of Research Animal Facility (2017-2021) Her research combines experimental human sample analysis with rodent models to elucidate drug-microbiota interactions. Scientific activities include ethics committee service in Nouvelle-Aquitaine and leading Inserm's AnimalPharm project for standardized animal research protocols. Key scientific contributions appear in journals like Nature Communications , PLoS Genetics , and Blood , with recent work (2024) addressing microbiota modulation of transplant outcomes .
Dr. Daohong Lin serves as an Assistant Professor in the Department of Pharmacology at New York Medical College's School of Medicine, where she leads NIH-funded research on renal potassium channel regulation. Her work bridges molecular physiology and clinical implications for electrolyte disorders. Education: M.D. in Clinical Medicine from Harbin Medical University Ph.D. in Pharmacology from Harbin Medical University/New York Medical College M.S. in Microbiology from Harbin Medical University Research Focus: Dr. Lin's laboratory investigates inwardly rectifying potassium channels (Kir) in renal epithelial cells, specializing in ROMK (Kir1.1) and Kir4.1/Kir5.1 heteromers. Her team employs molecular biology , protein chemistry , and electrophysiology to dissect mechanisms involving protein kinases, ubiquitination, and microRNA in dietary potassium regulation. Current projects examine calcineurin/mTOR signaling pathways and their roles in potassium excretion disorders. Publication Trends: Recent works (2022-2024) reveal expanding investigation into Kir channel interactions with sodium transporters and immunosuppressant effects. Her studies consistently connect molecular mechanisms to clinical conditions like hyperkalemia and hypokalemia, with increasing emphasis on therapeutic targets for electrolyte imbalances. Scientific Recognition: American Heart Association Scientific Development Grant (2011) Research Support & Mentorship: Principal Investigator for NIH R01 grants (2017, 2023) studying Kir5.1 regulation. Contributes to graduate pharmacology education through PSE curriculum instruction while mentoring junior researchers in renal physiology techniques. Editorial roles with American Journal of Physiology-Renal Physiology and Frontiers in Physiology demonstrate peer recognition. Professional Engagement: Active member of the American Physiological Society with ongoing collaborations in renal transport mechanisms research.
Catherine Yeung is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy. She also serves as an Investigator at the Kidney Research Institute under the Division of Nephrology. Education: PharmD, University of Michigan PhD in Medicinal Chemistry, University of Washington MPH in Epidemiology, University of Washington Her research focuses on optimizing medication use in patients with Chronic Kidney Disease (CKD), microfluidic models of kidney function, effects of uremia on drug transport, and impacts of microgravity on kidney structure. She pioneered a "kidney on a chip" microphysiological system for preclinical drug development. Recent publications highlight her work in organ-on-a-chip technology , drug toxicity mechanisms , and hepatic-renal pharmacokinetic interactions . Articles explore applications in preclinical testing, aristolochic acid nephrotoxicity, and CKD-related drug clearance.
Ardavan Akhavan, M.D. serves as Assistant Professor of Urology at Weill Cornell Medical College and Assistant Attending Urologist at NewYork-Presbyterian Hospital. He directs the pediatric robotic and minimally invasive surgery program at the Institute for Pediatric Urology, specializing in complex reconstructive procedures for infants and children with congenital urological disorders. His educational background includes a B.A. from Columbia College (2002) and an M.D. from the University of Pittsburgh School of Medicine (2007), followed by general surgery and urology residencies at Mount Sinai Medical Center and a pediatric urology fellowship at Seattle Children's Hospital. Dr. Akhavan's research focuses on advancing robotic surgical techniques for pediatric hydronephrosis, vesicoureteral reflux, and neurogenic bladder conditions. His work integrates fetal urology interventions with innovative stone management protocols, emphasizing minimally invasive approaches that reduce hospitalization and accelerate recovery. Recent publications demonstrate leadership in establishing evidence-based standards for robotic surgery in infants and complex reconstructive cases. His scientific contributions have earned recognition including Baltimore Magazine's Top Doctor award. Clinical expertise spans robotic mitrofanoff appendicovesicostomy, fetal lower urinary tract obstruction management, and pediatric kidney stone treatment. Top Doctor by Baltimore Magazine As former Director of Pediatric Minimally Invasive and Robotic Surgery at Johns Hopkins, he developed national training protocols while leading the Fetal Surgery and Kidney Stone Programs. Current clinical work at Weill Cornell emphasizes accessibility through video visits and multilingual patient education resources. His surgical outcomes research informs national guidelines for pediatric robotic procedures and ERAS implementation. Dr. Akhavan directs the Upper East Side campus pediatric urology team, maintaining active collaborations with fetal medicine specialists and nephrologists to provide comprehensive care for complex congenital conditions.
Dr. Zhongwei Li is an Associate Professor at the Keck School of Medicine of USC, affiliated with the Department of Stem Cell Biology and Regenerative Medicine. Trained as a stem cell biologist, his research focuses on kidney regeneration, organoid engineering, and pluripotent stem cell biology. He holds a PhD from Tsinghua University (2007–2012) and completed postdoctoral training at the Salk Institute. His lab combines stem cell technologies, genome editing, and bioengineering to develop kidney organoids for disease modeling and transplantation therapies. Education: PhD in Stem Cell Biology, Tsinghua University, 2012 Bachelor’s Degree, Sichuan University, 2007 Research interests include: Kidney organoid patterning and maturation Stem cell differentiation pathways (BMP/Smad/DUSP9/ERK) 3D culture systems for nephron progenitors Applications in kidney disease modeling and regenerative medicine Awards include the NIH Director’s New Innovator Award (2022), USC’s “Heros Among Us” Medal (2022), and Tsinghua University’s Outstanding PhD Thesis Award (2012). His lab integrates molecular biology, developmental biology, and bioinformatics to engineer synthetic kidney tissues. Current projects aim to create functional kidney organoids and explore their therapeutic potential.
Edgar J. Hernandez is a Research Assistant Professor in the Department of Biomedical Informatics at the University of Utah School of Medicine. He holds a PhD in Ecology, Systematics, and Evolution from the University of Missouri and a Bachelor's in Biology from Universidad Nacional de Colombia. His research bridges biostatistics, artificial intelligence, and clinical data to improve healthcare outcomes, particularly in personalized medicine and genomic diagnostics. He leads computational efforts in the Yandell lab, focusing on predictive modeling of genetic-clinical interactions, multi-omics analysis, and developing tools for diagnosing rare diseases using next-generation sequencing. His expertise spans applications in pediatric cardiology, nephrology, oncology, and metabolic disorders. Collaborations with consortia and industry partners emphasize translating genomic insights into clinical practice. Notable contributions include AI-driven risk stratification for perinatal mortality and cardiovascular outcomes, as well as genomic forecasting tools for congenital heart surgery outcomes. His work integrates electronic health records (EHR) and machine learning to address complex health challenges, such as identifying novel molecular signatures in multisystem inflammatory syndrome in children (MIS-C). Hernandez’s research portfolio reflects interdisciplinary innovation, with a focus on improving genomic information utilization for therapeutic advancements. His computational methods include probabilistic graphical models, natural language processing, and explainable AI frameworks to enhance diagnostic precision and predictive accuracy in healthcare.
Barbara Alexander is Billy S. Guyton Distinguished Professor directing the Analytical and Assay Laboratory at UMMC. Her NIH-funded research investigates developmental programming of hypertension, particularly sex-specific mechanisms in low birth weight offspring. Landmark studies established renal denervation and RAS modulation as key mechanisms in fetal programming of hypertension. Recent work explores therapeutic interventions for preeclampsia and IUGR. Honored with the Harriet Dustan Award and APS Fellowship.
John Demko, MD is an Assistant Adjunct Professor in the School of Medicine at the University of California, San Francisco (UCSF). His research focuses on renal physiology, ion transport mechanisms, and metabolic regulation, with a particular emphasis on mTORC2 signaling pathways and potassium homeostasis. He has contributed to studies on glomerulopathy, aldosterone-independent potassium secretion, and clinical trials addressing hyponatremia management in hospitalized patients. Education: MD from the University of Pittsburgh School of Medicine (2017), Internal Medicine Residency at UCSF (2019), and Nephrology Fellowship at UCSF (2023). His work integrates basic science and clinical medicine, spanning nephrology, hypertension, and endocrine disorders. Key research interests include renal glucose reabsorption, epithelial sodium channel regulation, and the role of dietary potassium in renal function. He has published in high-impact journals such as J Am Soc Nephrol and J Gen Intern Med , collaborating with co-authors like David Pearce, Timothy Judson, and Robert Weber.
Dr. Mehmet Altintas is Associate Professor in Internal Medicine at UTMB, focusing on molecular mechanisms of kidney disease and podocyte biology. Research Focus: Investigates soluble urokinase receptor (suPAR) in diabetic kidney disease, podocyte injury mechanisms, and genetic/environmental factors in renal pathologies. Current projects examine developmental origins of kidney function. Publications: Studies in Science Translational Medicine , Kidney International , and Nature Communications explore suPAR's role as an immunotoxin, Rac1 signaling in podocytes, and cytoskeletal stabilization therapies. Grants: Principal investigator on NIH R01 projects studying suPAR in cardiovascular-kidney disease intersections and genetic risks in minority populations.
Lori O’Brien, PhD, is an Associate Professor in the Department of Cell Biology and Physiology at the UNC School of Medicine, University of North Carolina at Chapel Hill. Her research focuses on understanding kidney development and disease mechanisms, particularly nephron progenitor maintenance, podocyte biology, and Wilms’ tumor transformation. She holds affiliations with the Cell Biology and Physiology Curriculum and the UNC Kidney Center. Education: Bachelor of Science in Bacteriology, University of Wisconsin-Madison PhD in Biochemistry, University of Wisconsin-Madison Postdoctoral training at Massachusetts General Hospital/Harvard University and the University of Southern California Research Interests: Her lab investigates regulatory networks governing nephron progenitor cell behavior, podocyte development, and disease-related cellular changes. Techniques include developmental biology, genetics, high-throughput sequencing, and imaging. Key areas include: - Nephron progenitor maintenance and kidney disease susceptibility - Wilms’ tumor transformation mechanisms - Podocyte architecture and disease progression Publications: Recent work includes studies on kidney organoid vascularization, sensory innervation mapping, and ferroptosis in kidney injury. Articles span developmental biology, cell biology, and kidney disease mechanisms. Awards: 2016 Maren Scholar 2015 Broad Postdoctoral Fellowship 2010 NIH/NIDDK Postdoctoral Fellowship 2009 North-East Society for Developmental Biology Best Poster Labs/Teams: Active in the UNC Kidney Center and collaborates on projects involving kidney regeneration and disease modeling.
Ana Lidia Flores-Mireles is the Janet C. and Jeffrey A. Hawk Collegiate Associate Professor in the Department of Biological Sciences at the University of Notre Dame, College of Science. Her research focuses on microbial pathogenesis in catheter-associated urinary tract infections (CAUTIs), with emphasis on host-pathogen interactions, biofilm formation, and antibiotic resistance. Her research interests include: Microbial pathogenesis in CAUTIs Enterococcal virulence mechanisms Host inflammatory responses Immune evasion by uropathogens Development of antibiotic-sparing therapies Medical device-associated infections Her recent publications span high-impact journals such as Nature Communications , Science Advances , and PNAS , reflecting a strong focus on polymicrobial biofilms, novel antimicrobial strategies, CRISPR-based genetic tools, and host susceptibility factors in CAUTIs. The work demonstrates a consistent trajectory toward understanding and preventing healthcare-associated infections through interdisciplinary approaches combining microbiology, immunology, and biomedical engineering. Scientific recognitions include: Selected for Stat Madness competition (2022) Featured in 'This Week in Microbiology' podcast Selected for 2024 IAI New Voices in Microbiology Collection Commentary in Nature Chemical Biology Multiple media highlights in UroToday, Science Daily, Healthcare-in-Europe, and others Dr. Flores-Mireles has actively mentored numerous students and researchers, as evidenced by her co-authorship with trainees on multiple publications. Her lab investigates both host and pathogen determinants of infection, aiming to develop novel therapeutic interventions. She has secured significant research attention and collaboration, particularly in the areas of biofilm formation, catheter coatings, and microbial co-occurrence in clinical settings. The Flores-Mireles Lab is an active research team focused on understanding how urinary catheterization predisposes patients to infections, with ongoing projects in bacterial and fungal pathogenesis, host immune responses, and innovative prevention strategies.
Cecilia Canessa is a Professor of Cellular and Molecular Physiology at Yale School of Medicine, where she maintains an active research laboratory focused on ion channel physiology. Her work bridges cellular physiology, molecular biology, and neuroscience through the study of sodium channels in both epithelial and neuronal contexts. Dr. Canessa's primary research interests center on two structurally related but functionally distinct sodium channels: the Epithelial Na + Channel (ENaC) and Acid Sensing Ion Channels (ASIC). Her laboratory examines the structure, function, and regulation of these channels using a diverse array of experimental approaches including electrophysiology (patch-clamp, two-electrode voltage clamp, short-circuit current), molecular cloning from evolutionary distant species, channel modifications, and expression in oocytes, cell lines, and transgenic or knockin mice. Her work on ENaC focuses on mechanisms regulating activity, expression, and trafficking in epithelial cells, particularly the role of serum- and glucocorticoid-induced kinase (Sgk1). Her ASIC research explores biophysical properties and gating mechanisms in central and peripheral nervous system neurons, investigating their roles in nociception, mechanoperception, and synaptic transmission modulation. Analysis of Dr. Canessa's publication record spanning over two decades reveals consistent focus on ion channel structure-function relationships, with particular emphasis on ENaC and ASIC channels. Her research demonstrates strong evolutionary perspective, examining channel properties across species from fish to mammals. The work shows progression from basic channel characterization to more complex regulatory mechanisms involving kinases like SGK1 and their role in physiological processes. Her research maintains strong connections between basic molecular mechanisms and their implications for human physiology and disease. Dr. Canessa's laboratory employs a broad methodological approach combining molecular biology, electrophysiology, and transgenic models to address fundamental questions in cellular physiology. Her work has established important connections between channel structure and function, particularly regarding how specific domains regulate channel properties and how these channels contribute to physiological processes in both epithelial and neuronal tissues.
Stefano Salciccia is an Associate Professor at Sapienza University of Rome's Faculty of Medicine, Department of Maternal-Infant and Urological Sciences. With over 20 years of clinical and research experience since his medical graduation in 2003, he specializes in urological oncology with particular focus on prostate cancer diagnostics and treatment strategies. His academic journey includes specialization in Urology (2008), PhD in New Technologies in Surgery (2012), and National Scientific Qualification as Professor of II Fascia (2014). Dr. Salciccia's research spans multiple critical areas in urological oncology, with primary emphasis on prostate cancer. His work investigates the application of multiparametric MRI for optimizing diagnostic pathways, nerve-sparing surgical techniques, and management of biochemical recurrence. He has made significant contributions to understanding the neuroendocrine system's role in prostate cancer progression and developed innovative approaches for urinary continence rehabilitation after radical prostatectomy. His research integrates clinical practice with laboratory investigations, particularly examining inflammatory pathways in prostate tissue and evaluating herbal compounds like Serenoa repens. Analysis of his 15 most recent publications reveals a consistent focus on improving diagnostic accuracy while minimizing patient morbidity. His work bridges imaging technology (particularly multiparametric MRI), biomarker development (PCA3 test), and clinical decision-making algorithms. A notable trend is his emphasis on multidisciplinary approaches to prostate cancer management, reflected in his leadership of the Prostate Cancer Unit at Policlinico Umberto I since 2010. Best Poster Award, European Association of Urology (EAU-Paris 2012): 'Is prostate biopsy still necessary?' Best Poster Award, European Association of Urology (EAU-Paris 2012): 'Use of multiparametric MR with neurovascular bundle evaluation' Winner of Excellence Research Award, Sapienza University 2011: 'Evaluation of inflammatory factors in continuous lines of prostatic cells lncap and PC3 and in primary cultures of cells derived from prostate adenocarcinoma' As an active member of the Prostate Cancer Unit since 2010, Dr. Salciccia coordinates multidisciplinary care involving radiologists, radiotherapists, oncologists, and pathologists, managing approximately 550 patients annually including 100 prostate cancer cases. He has participated in multiple international clinical trials including ZOMETA, BIOXELL, and POSEIDON studies. His teaching activities include seminars for nursing students and instruction in integrated pathology courses focusing on urology. Dr. Salciccia leads the Prostate Cancer Unit at Policlinico Umberto I-University 'La Sapienza' of Rome, which operates as a multidisciplinary center for comprehensive prostate cancer management from diagnosis through medical and surgical therapy to oncological and functional follow-up. The unit evaluates approximately 550 patients annually, performs 250 multiparametric MRIs, conducts 200 prostate biopsies, and performs 40 radical prostatectomies per surgeon annually. In 2015, he authored the multidisciplinary guidelines for prostate cancer management at this institution.
Fredric Coe is a Professor in the Department of Medicine-Nephrology at the University of Chicago's Pritzker School of Medicine. With a career spanning over six decades, Dr. Coe has established himself as a leading authority in the field of nephrology, particularly in the study of kidney stone formation and treatment. Dr. Coe received his BA in Liberal Arts (1955), BS in Biology (1957), and MD (1961) from the University of Chicago. He completed his medical residency at Michael Reese Hospital in Chicago (1965) and a fellowship in Nephrology at the University of Texas Southwestern Medical School in Dallas (1969). Dr. Coe's research primarily focuses on the pathophysiology of kidney stone formation, with particular emphasis on calcium metabolism, renal physiology, and urolithiasis. His pioneering work on Randall's plaque has fundamentally changed our understanding of how calcium-based kidney stones form. His investigations into the mechanisms of calcium oxalate crystallization, idiopathic hypercalciuria, and the metabolic connections to stone disease have shaped modern approaches to stone prevention and treatment. Recent work explores precision medicine applications, immune responses in stone disease, and racial disparities in kidney stone risk factors. Analysis of Dr. Coe's extensive publication record reveals an evolution from foundational biochemical studies of crystal inhibitors in the 1980s to sophisticated molecular and genomic investigations in recent years. His current research demonstrates continued innovation with spatial transcriptomics to map kidney stone pathology and investigate the relationship between metabolic conditions like insulin resistance and stone formation. Dr. Coe has received numerous professional recognitions for his contributions to nephrology and urology, with his seminal 1992 New England Journal of Medicine review on kidney stone pathogenesis having been cited over 150 times. His work continues to influence clinical guidelines and research directions in the field of nephrolithiasis. Throughout his career, Dr. Coe has maintained a robust research program with extensive collaborations, most notably with Dr. Elaine Worcester. His work has been supported by multiple grants that have enabled comprehensive investigations into kidney stone pathogenesis, prevention strategies, and treatment approaches. He has mentored generations of researchers and clinicians in the field of nephrolithiasis. Dr. Coe leads or is a key member of a multidisciplinary research team at the University of Chicago that includes nephrologists, urologists, basic scientists, and engineers. This team utilizes advanced techniques including micro-CT imaging, proteomics, and spatial transcriptomics to investigate the complex mechanisms of kidney stone disease and develop more effective prevention and treatment strategies.
